Associated Urologists of North Carolina

Raleigh, North Carolina 27612

3 studies enrolling now · 26 studies all time

What they study most

Androgen Resistant Prostatic Cancer, BPH With Symptomatic Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia, Bladder Cancer, Cancer of Prostate, Dietary Hyperoxaluria, Enteric Hyperoxaluria, Healthy Volunteers, Hyperoxaluria, Kidney Stones, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Metastatic Castration-resistant Prostate Cancer

Studies at this site

• LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve — Recruiting now
• A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer — Recruiting now
• A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms — Recruiting now
• Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T — Recruiting now
• ProVee Urethral Expander System IDE Study (ProVIDE) — Running, not enrolling
• Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate — Completed
• A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases — Completed
• A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer — Running, not enrolling
• Effectiveness of eCoin at Sensory and Subsensory Amplitudes — Completed
• QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer — Running, not enrolling
• Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB) — Completed
• A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical Prostatectomy — Completed
• Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent — Stopped early
• Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence — Completed
• Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects — Stopped early
• Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer — Stopped early
• Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria — Stopped early
• Vesair Clinical Trial — Stopped early
• BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence — Completed
• A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) — Completed
• Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI) — Completed
• A Registry for Hereditary Cancer Risk Assessment and Genetic Testing — Completed
• Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria — Completed
• Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies Disease — Completed
• OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder — Completed
• Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days — Completed